AVI BioPharma (AVII) Signs Contract with US Defense Threat Reduction Agency for Development of Therapeutics Targeting H1N1 Swine Flu
Tweet Send to a Friend
AVI BioPharma, Inc. (NASDAQ: AVII) is under contract with the U.S. Defense Threat Reduction Agency for development of one or ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
